With the recent IPO of GoodRx, drug price transparency – at least on the consumer side – is having a moment. But what about at the patient’s bedside? In this week’s podcast, we sit down with Carm Huntress, CEO of RxRevu, a StartUp Health company that for seven years has been bringing drug price data to doctors at the point of care so they can make smarter decisions for their patients.